Kastelein Johannes Jacob Pieter
Chief Scientific Officer
DirectorOfficer
Latest Insider Transactions
Showing 10 of 17 transactions (past 365 days)
| 2026-08-25 | 2026-08-24 | NAMS Newamsterdam Pharma Co N.V. | CSO | Exercise Conversion | 125,000 | $0.00 | $0 |
| 2026-08-25 | 2026-08-24 | NAMS Newamsterdam Pharma Co N.V. | CSO | Exercise Conversion | 125,000 | $0.00 | $0 |
| 2026-08-25 | 2026-08-24 | NAMS Newamsterdam Pharma Co N.V. | CSO | Sale | 125,000 | $26.91 | $3,363,750 |
| 2026-03-10 | 2026-03-09 | NAMS Newamsterdam Pharma Co N.V. | CSO | Sale | 101,409 | $30.29 | $3,071,679 |
| 2026-03-10 | 2026-03-09 | NAMS Newamsterdam Pharma Co N.V. | CSO | Exercise Conversion | 101,409 | $0.00 | $0 |
| 2026-03-10 | 2026-03-09 | NAMS Newamsterdam Pharma Co N.V. | CSO | Exercise Conversion | 101,409 | $0.00 | $0 |
| 2026-03-10 | 2026-03-06 | NAMS Newamsterdam Pharma Co N.V. | CSO | Sale | 94,124 | $30.32 | $2,853,840 |
| 2026-03-10 | 2026-03-06 | NAMS Newamsterdam Pharma Co N.V. | CSO | Exercise Conversion | 94,124 | $0.00 | $0 |
| 2026-03-10 | 2026-03-06 | NAMS Newamsterdam Pharma Co N.V. | CSO | Exercise Conversion | 94,124 | $0.00 | $0 |
| 2026-03-10 | 2026-03-05 | NAMS Newamsterdam Pharma Co N.V. | CSO | Sale | 104,467 | $30.30 | $3,165,350 |
NAMS
CSO
Exercise Conversion
$0
125,000 shares @ $0.00
Filed 2026-08-25Trade 2026-08-24
Newamsterdam Pharma Co N.V.NAMS
CSO
Exercise Conversion
$0
125,000 shares @ $0.00
Filed 2026-08-25Trade 2026-08-24
Newamsterdam Pharma Co N.V.NAMS
CSO
Exercise Conversion
$0
101,409 shares @ $0.00
Filed 2026-03-10Trade 2026-03-09
Newamsterdam Pharma Co N.V.NAMS
CSO
Exercise Conversion
$0
101,409 shares @ $0.00
Filed 2026-03-10Trade 2026-03-09
Newamsterdam Pharma Co N.V.NAMS
CSO
Exercise Conversion
$0
94,124 shares @ $0.00
Filed 2026-03-10Trade 2026-03-06
Newamsterdam Pharma Co N.V.NAMS
CSO
Exercise Conversion
$0
94,124 shares @ $0.00
Filed 2026-03-10Trade 2026-03-06
Newamsterdam Pharma Co N.V.Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.